stockrowHims & Hers Health, Inc. (HIMS) vs Dr. Reddy's Laboratories Ltd (RDY)
- Hims & Hers Health, Inc. HIMS 24.11 −9.56%
- Dr. Reddy's Laboratories Ltd RDY 14.53 −1.62%
Hims & Hers Health, Inc. and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $12.1B against $5.6B — 2.2× the size. Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Dr. Reddy's Laboratories Ltd trades at 44.4×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against −15.5%. Dr. Reddy's Laboratories Ltd has the higher net margin (8.06% vs −5.51%) and the higher return on invested capital (4.77% vs −11.4%). Across the 20 metrics below, Dr. Reddy's Laboratories Ltd leads on 11 and Hims & Hers Health, Inc. on 9.
Valuation
Profitability
| Metric | HIMS | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 49.16% | 53.51% |
| Operating margin | (5.99%) | 9.20% | 0.00% |
| Net margin | (5.51%) | 8.06% | (2.45%) |
| Free cash flow margin | 3.22% | 2.88% | 0.00% |
| Return on equity | (32.03%) | 6.60% | (0.80%) |
| Return on assets | (5.16%) | 4.44% | (1.67%) |
| Return on invested capital | (11.38%) | 4.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack